Revvity launches SaaS platform to accelerate drug development – ET HealthWorld
Waltham: In order to drive scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development, Revvity, Inc. today announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform. The new solution from Revvity Signals Software, the software and informatics arm of Revvity, will be available worldwide. The SaaS platform … Read more